Capstone Investment Advisors’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Capstone Investment Advisors’s Portfolio CPXX Stock Details CPXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-25,000	Closed	-$754K	–	1026
2016 Q2	$754K	Buy	+25,000	New	+$507K	0.01%	407

Capstone Investment Advisors's CPXX Position: Q3 2016 in Review

Capstone Investment Advisors sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 25,000 shares — an estimated $754K sold.

Capstone Investment Advisors first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $754K in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

Capstone Investment Advisors reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
Capstone Investment Advisors sold 25,000 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $754K.
Capstone Investment Advisors first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
Capstone Investment Advisors's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $754K in Q2 2016.
0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Capstone Investment Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.